For most parents, newborn screening tests are a barely perceptible safety net. But for the small minority whose babies get ...

PKU is a rare, inherited metabolic disorder that prevents the body from breaking down the amino acid phenylalanine. Untreated phenylketonuria can lead to brain damage, intellectual disabilities ...

PKU is a rare genetic disease that manifests at birth and is marked by an inability to break down phenylalanine (phe), an amino acid that is commonly found in many foods. Left untreated ...

Given their life-saving potential, newborn screenings should not be seen as optional but as a fundamental part of postnatal ...

PKU is a rare genetic disease that manifests at birth and is marked by an inability to break down phenylalanine, an amino acid that is commonly found in many foods. Left untreated, high levels of ...

The Argentina inborn errors of protein metabolism (IEPM) market was valued at US$ 268.2 million in 2023 and is expected to achieve a market valuation of US$ 664.0 million by 2032. This impressive ...

Securities.io is not an investment adviser, and this does not constitute investment advice, financial advice, or trading advice. Securities.io does not recommend that any security should be bought, ...

PALYNZIQ is the first and only enzyme therapy approved to treat adults with PKU. BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.) Detailed results from the PEGASUS study will ...

Market OverviewThe global Newborn Screening Market is valued at USD 3.44 Billion in 2024 and is projected to reach a value of ...

Serious and potentially deadly complications, like sepsis, can occur if left untreated. Brits are being urged to look out for the signs of urinary tract infections (UTIs) to avoid serious health ...